Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion

Houman Ashrafian1, Charles Redwood, Edward Blair

  • 1Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Insights

Genetic mutations causing hypertrophic cardiomyopathy (HCM) likely impair energy production, not contraction. This energy deficit may explain HCM

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Metabolic Disorders

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart disease primarily linked to sarcomeric protein defects.
  • Previous theories suggested impaired contraction triggers compensatory hypertrophy, but evidence is inconsistent.
  • Sarcomeric dysfunction in HCM requires re-evaluation of its underlying mechanisms.

Purpose of the Study:

  • To investigate the role of energy metabolism in the pathogenesis of sarcomeric hypertrophic cardiomyopathy (HCM).
  • To propose a new model for HCM development based on impaired ATP utilization.
  • To explore the implications of compromised energetics for HCM clinical presentation and treatment.

Main Methods:

  • Analysis of mutant contractile protein function.
  • Utilizing mouse models of HCM.
  • Reviewing clinical studies on hypertrophic cardiomyopathy patients.

Main Results:

  • Sarcomeric HCM mutations are associated with inefficient ATP utilization, suggesting an energy deficit.
  • Mutations in metabolic genes also cause HCM-like phenotypes, supporting a role for energetics.
  • Compromised cellular energetics align with clinical observations like delayed onset and asymmetrical hypertrophy.

Conclusions:

  • Inefficient ATP utilization, or energy depletion, is a proposed central mechanism in sarcomeric HCM.
  • This energetic hypothesis may explain key clinical features of HCM.
  • Understanding HCM energetics could inform new therapeutic strategies for HCM and other cardiac hypertrophy conditions.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...